Key factors for successful cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat diffuse malignant peritoneal mesothelioma: results from specialized peritoneal cancer center in China
CONCLUSIONS: CRS + HIPEC for DMPM treatment resulted in prolonged survival with acceptable safety. Tumor pathology and SAEs are key factors for successful CRS + HIPEC.PMID:35485308 | DOI:10.1080/02656736.2022.2066728
Source: International Journal of Hyperthermia - Category: Internal Medicine Authors: Yan-Dong Su Zhi-Ran Yang Xin-Bao Li Yang Yu Xue-Mei Du Yan Li Source Type: research
More News: Asbestosis | Cancer | Cancer & Oncology | Chemotherapy | China Health | Databases & Libraries | Internal Medicine | Mesothelioma | Pathology | Peritoneal Cancer